This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Efficacy and Safety of Upadacitinib as an Induction Therapy for Patients With Moderately‐to‐Severely Active Ulcerative Colitis: Combined Results From 382 Subjects in the Phase 2b Study U‐ACHIEVE: 215. (October 2019)
Record Type:
Journal Article
Title:
Efficacy and Safety of Upadacitinib as an Induction Therapy for Patients With Moderately‐to‐Severely Active Ulcerative Colitis: Combined Results From 382 Subjects in the Phase 2b Study U‐ACHIEVE: 215. (October 2019)
Main Title:
Efficacy and Safety of Upadacitinib as an Induction Therapy for Patients With Moderately‐to‐Severely Active Ulcerative Colitis: Combined Results From 382 Subjects in the Phase 2b Study U‐ACHIEVE